38229741|t|Positive Allosteric Modulators of alpha7 Nicotinic Acetylcholine Receptor for the Treatment of Several Central Nervous System Diseases.
38229741|a|The invention in this patent application relates to spirocyclopropane-2-carboxamide derivatives represented generally by formula 1. These compounds are positive allosteric modulators of alpha7 nAChR and may be useful in preventing, treating, or ameliorating central nervous system diseases and disorders such as cognitive impairments in Alzheimer's disease, Parkinson's disease, schizophrenia, and L-DOPA-induced dyskinesia as well as inflammation and cough.
38229741	34	73	alpha7 Nicotinic Acetylcholine Receptor	Gene	1139
38229741	103	134	Central Nervous System Diseases	Disease	MESH:D002493
38229741	188	219	spirocyclopropane-2-carboxamide	Chemical	-
38229741	394	425	central nervous system diseases	Disease	MESH:D002493
38229741	448	469	cognitive impairments	Disease	MESH:D003072
38229741	473	492	Alzheimer's disease	Disease	MESH:D000544
38229741	494	513	Parkinson's disease	Disease	MESH:D010300
38229741	515	528	schizophrenia	Disease	MESH:D012559
38229741	534	540	L-DOPA	Chemical	MESH:D007980
38229741	549	559	dyskinesia	Disease	MESH:D004409
38229741	571	583	inflammation	Disease	MESH:D007249
38229741	588	593	cough	Disease	MESH:D003371
38229741	Positive_Correlation	MESH:D007980	MESH:D004409
38229741	Association	MESH:D002493	1139

